GW Pharma’s cannabis drug OK’d by European Medicines Agency panel

GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex. The CHMP is responsible for preparing the European Medicines Agency (EMA)’s opinions on questions related to the marketing of human medicines. The CHMP opinion was adopted July 25, and the final decision now rests

GW Pharma’s cannabis drug OK’d by European Medicines Agency panel is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

[Read More ...]

addiitional information, George Scorsis

Originally posted on GW Pharma’s cannabis drug OK’d by European Medicines Agency panel via George Scorsis Medical Marijuana News